You are Trying to View a Free Article

Daily News You Can't Find Anywhere Else

U.S. Patent Office Approves World's First Heat-Stable Rotavirus Vaccine, an Industrial Info Market Brief

default

Industry Segment: Market Brief | Word Count: 132 Words
Attachment: India pharma plants 0819

The United States Patent and Trademark Office (USPTO) has granted approval to Rotasiil, the world's first heat-stable rotavirus vaccine. It was developed by Serum Institute of India, which produces and sells more doses globally than any other vaccine manufacturer, and the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health.

Subscribe Now! All Fields Required...

Standard Membership - Free